Weihao Xu

President of Harbour BioMed, US & Chief Business Officer at Harbour BioMed

Mr. Weihao Xu, is the Chief Financial Officer and Chief Business Officer. Before HBM, Mr. Xu served as Chief Finance Officer at Alphamab Oncology, CASI Pharmaceuticals, and 111 Inc. Prior to that, he was active in the investment industry, working as the Portfolio Manager for Matthews Asia and several other international investment institutions, where he was responsible for global equity investments.

Org chart

Teams

CEO and Executive Team

3 members

Leadership Team

3 members

Timeline

  • President of Harbour BioMed, US & Chief Business Officer

    Current role

  • Chief Strategy Officer

  • CFO & Chief Business Officer

View in org chart